MCC
EVGN icon

Malaga Cove Capital’s Evogene EVGN Stock Holding History

Malaga Cove Capital’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,200
Closed -$9K – 179
2024
Q1 		$9K Hold
1,200
– – ﹤0.01% 176
2023
Q4 		$10.1K Hold
1,200
– – ﹤0.01% 179
2023
Q3 		$7.04K Buy
+1,200
New +$10.5K ﹤0.01% 171

Other funds holding EVGN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
JIC
Joel Isaacson & Co New York $3.02B AUM 21.81% 1-Year Est. Return

Malaga Cove Capital's EVGN Position: Q2 2024 in Review

Malaga Cove Capital sold out of Evogene (EVGN) in Q2 2024, closing a stake of 1,200 shares — an estimated $9K sold.

Malaga Cove Capital first reported a position in EVGN in Q3 2023 and held it in 3 quarters. The position peaked at $10.1K in Q4 2023. 28 funds tracked by Wall St. Rank hold EVGN as of Q2 2024.

  • Malaga Cove Capital reported no remaining Evogene position as of Q2 2024 after selling out during the quarter.
  • Malaga Cove Capital sold 1,200 Evogene shares in Q2 2024, an estimated $9K.
  • Malaga Cove Capital first reported a position in Evogene in Q3 2023 and held it in 3 quarters.
  • Malaga Cove Capital's Evogene position peaked at $10.1K in Q4 2023.
  • 28 funds tracked by Wall St. Rank held Evogene as of Q2 2024.

Based on Malaga Cove Capital's 13F filing for Q2 2024, filed 7 Aug 2024.